How do you bridge the gap between prophylactic and therapeutic vaccines?
"A vaccine that âtreats' a disease before it causes morbidity would bridge the gap between prophylactics and therapeutics."
Download this presentation to discover more about bridging the gap between prophylactic and therapeutic vaccines including:
Â· The next-best thing to prophylaxis
Â· Therapy of still-healthy patients requires validated biomarkers and a diagnostic-compliant target population
Â· Avoiding adjuvant IN vaccine formulations reduces adjuvant-specific regulatory risks
Â· ProCervix, first clinical-stage therapeutic vaccine to prevent disease progression in healthy HR-HPV-infected patients
Dr Benedikt Timmerman, Chief Executive Officer, Genticel
To learn more about this and the other topics discussed at this the World Vaccine Congress Lyon 2012, please click here >